| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GLI1 | CTRPv2 | pan-cancer | AAC | -2.7 | 0.002 |
| mRNA | OS9 | CTRPv2 | pan-cancer | AAC | -0.56 | 0.0003 |
| mRNA | PIP4K2C | CTRPv2 | pan-cancer | AAC | -0.56 | 0.002 |
| mRNA | DTX3 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | SLC26A10 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.003 |
| mRNA | TNNT1 | CTRPv2 | pan-cancer | AAC | -0.34 | 4e-05 |
| mRNA | ARHGEF25 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.003 |
| mRNA | CDK5 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.0002 |
| mRNA | BOK | CTRPv2 | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | TSPAN31 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.005 |
